On May 9, the 2024VBEF 'Future Medical Top 100' list was officially released. Baisaifei was rated as an outstanding product in the upstream of the pharmaceutical device supply chain - high-value consumable raw materials TOP5 , and its 'new mechanism anticoagulant coating product' was selected into the 2024 VBEF medical and health industry innovative product list!
As a functional coating supplier of key raw materials in the upstream of medical devices, Baisaifei has created a technical service platform covering the entire industry chain of high-end functional coatings . It has developed multiple series of medical functional coating products, automated coating equipment and coating testing instrument products with independent intellectual property rights and international competitiveness, and provides customers with professional technical services throughout the product life cycle from design and development to stable mass production. Being rated as a TOP5 enterprise of high-value consumable raw materials this time is not only recognition of Besaifei's outstanding performance in the upstream field of the pharmaceutical and device supply chain, but also recognition of our continuous innovation and continuous improvement of product quality and service levels.
It is worth mentioning that Besaifei's new mechanism anticoagulant coating series products have been listed on the 2024 VBEF Medical and Health Industry Innovative Product List with their breakthrough technological innovation and important clinical application value. Bysaifei assists many downstream customers in device innovation with anticoagulant coatings, providing professional service guarantees covering the entire product life cycle. At the same time, Bysaifei is also the leading drafter of domestic anticoagulant coating performance evaluation standards.
In the future, Baisaifei will continue to leverage its advantages accumulated over more than 20 years of expertise, actively promote the development of high-end functional coatings to a higher level and in a wider range of fields, and work with downstream partners to jointly promote the development of the industry.
List introduction
The Future Medical Top 100 list is a domestic innovative medical field list for non-listed companies launched by VB100, Artery Network, and Eggshell Research Institute. It aims to select Chinese innovative medical practitioners who truly represent future medical care, discover the core strength of my country's future medical industry, and promote the innovation and transformation process of the health medical industry.
In order to explore upstream products and solutions with innovative potential in the pharmaceutical and device supply chain, and select industry models to further promote the progress and upgrading of the supply chain industry, Arterial Network VB100 launched the 'Excellent Products in the Upstream of the Pharmaceutical and Device Supply Chain' selection activity. Through industry report reading, investor interviews, reporter interviews and other multi-directional and all-round insights and explorations, the organizing committee considered market demand and development potential, technological innovation significance, industrial chain strategic value and other aspects to select the top ten upstream value areas of the pharmaceutical and medical device supply chain and select the TOP5 outstanding products in each field.。
The VBEF Health Industry Innovation Product List selects innovative products in the medical and health field, aiming to discover and display innovative medical and health products and innovative solutions that represent the technological advancement of China's 3rd to global medical and health industries, have high domestic substitution value, meet clinical unmet needs, have global competitiveness, and have outstanding industry-leading effects. The VBEF Health Industry Innovation Product List selects innovative products in the medical and health field, aiming to discover and display innovative medical and health products and innovative solutions that represent the technological advancement of the medical and health industry in China and even the world, have high domestic substitution value, meet clinical unmet needs, are globally competitive, and have outstanding industry-leading effects.。
About Baisaifei
Jiangsu Baisaifei Biotechnology Co., Ltd. is the leading domestic technical service platform for the entire industry chain of medical functional coatings, and is a leading enterprise and leader in the field of medical coatings. Based on the founder's more than 20 years of professional accumulation in the field of biomaterial surface interfaces and academic influence at home and abroad, it focuses on innovative research and development of biomaterial surface modification technology, and develops high-end functional coatings and related products with independent intellectual property rights and international competitiveness. Since its establishment, the company has gone through several expansions and four rounds of financing, and now has more than 30,000m of R&D and production space. It has cooperated with hundreds of medical device companies, including domestic and foreign listed companies and group companies, and assisted companies to obtain a large number of Class II and Class III medical device registration certificates, covering neurological intervention, cardiovascular intervention, non-vascular intervention, drainage, vascular spoon implantation, extracorporeal life support and other fields. Coating equipment and high-capacity coating production lines are sold at home and abroad. Jiangsu Baisaifei Biotechnology Co., Ltd. is the leading domestic technical service platform for the entire industry chain of medical functional coatings, and is a leading enterprise and leader in the field of medical coatings. Based on the founder's more than 20 years of professional accumulation in the field of biomaterial surface interfaces and academic influence at home and abroad, it focuses on innovative research and development of biomaterial surface modification technology, and develops high-end functional coatings and related products with independent intellectual property rights and international competitiveness. Since its establishment, the company has gone through several expansions and four rounds of financing, and now has more than 30,000m of R&D and production space. It has cooperated with hundreds of medical device companies, including domestic and foreign listed companies and group companies, and assisted companies to obtain a large number of Class II and Class III medical device registration certificates, covering neurological intervention, cardiovascular intervention, non-vascular intervention, drainage, intravascular implantation, extracorporeal life support and other fields. Coating equipment and high-capacity coating production lines are sold at home and abroad.
Coating categories include hydrophilic lubricating coatings, anticoagulant coatings, hydrophilic lubricating antibacterial coatings, hydrophobic coatings, anti-crystallization coatings, anti-fouling coatings, drug-releasing coatings, etc. The cooperation model includes coating liquid sales, coating equipment and coating testing instrument sales, coating ODM, coating inspection and testing, and coating customized R&D services.
According to public data from the State Intellectual Property Office, Baisaifei has become the company with the most applications and authorized patents in China in the global medical coating industry. It has also participated in a number of regulatory scientific research and the establishment of inspection and testing standards related to coated medical devices. It has formed a biomaterial surface modification technology as the core, integrating the research and development and production of coating materials, A comprehensive technical service and innovative product platform integrating advanced manufacturing of coating equipment, coating process development and customization, coating quality analysis instrument development and inspection and testing services, and research and development of new coated products, to create an internationally leading brand of independent and controllable biological functional coatings and related products, and promote the high-quality development of the health industry.
